dihexa cancer risk hgf c met targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c-MET receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is HGF/c-MET: A Promising Therapeutic Target
HGF c MET: A Promising Therapeutic Target in the Digestive System Cancers Frontiers Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



